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Abstract We previously described that NO' leads to destruction 
of ZnS clusters and release of Zn 2 + from various proteins 
including zinc finger transcription factors. To assess the 
relevance in living cells, we investigated, whether exogenous 
NO' leads to an increase of cytoplasmic and nuclear free Zn 2 + . 
L929 cells, mouse splenocytes, or rat aorta endothelial cells were 
labeled with Zinquin-E, a Zn2+-specific fluorophore, and were 
treated with two different spontaneous N O donors, S-nitroso-
cysteine or DETA/NO. Both NO donors strongly increased the 
Zn2+-dependent fluorescence in the cellular cytosol and also in 
nuclei as compared to controls. NO-dependent Zn 2 + release in 
splenocytes was quantitated by flow cytometry. These results 
show for the first time, that nitrosative stress mediates 
intracellular and intranuclear Zn 2 + release which may be 
relevant in altering gene expression patterns. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Following iron, zinc is the second most widely used tran-
sition metal in biology. Nearly 1% of the human genome 
codes for zinc finger-, ring finger- or the L I M domain-con-
taining proteins (for reviews see [1,2]). The common feature of 
these structures is that Z n 2 + is complexed, sometimes together 
with histidine imidazole nitrogens, by cysteine sulfur ligands, 
creating tertiary protein structural domains that specifically 
bind to D N A or R N A sequences. The zinc finger is by far 
the most prevalent DNA-binding motif. Many of these z inc-
sulfur cluster-containing proteins are involved in transcrip-
tion, replication, recombination or restriction. 
The radical nitric oxide (NO') generated from L-arginine by 
N O synthases is essential for several functions in physiology 
and the immune system. Under aerobic conditions, N O ' nitro-
sylates free cysteine SH groups of proteins [3] and inactivates 
proteins with cysteine residues in or near their active sites 
[4,5]. N O ' has been shown to mediate Z n 2 + release in vitro 
from the zinc-sulfur cluster protein metallothionein via S-ni-
trosylation and subsequent formation of disulfides and to in-
hibit the DNA-binding activity of the zinc finger transcription 
factor LAC9 [6]. N O ' also inhibits the D N A repair enzyme 
Fpg containing a zinc finger [7]. However, at present it is 
unclear whether N O ' can possibly mediate changes in gene 
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expression via modification of zinc finger transcription fac-
tors. To gain further insight into Z n 2 + homeostasis in living 
cells and its modification by NO ' , we designed experiments to 
study whether nitrosative stress in cells mediates increases in 
detectable free Z n 2 + concentrations. 
2. Materials and methods 
2.1. Materials 
ZnCl2, L-histidine-HCl, and NaN0 2 were purchased from Merck 
(Darmstadt, Germany), L-cysteine-HCl, propidium iodide and 
/V/VArW'-tetrakis-(2-pyridylmethyl)ethylenediamine (TPEN) from Sig-
ma (Deisenhofen, Germany), Hanks balanced salt solution (HBSS) 
from Gibco (Heidelberg, Germany), and ethyl(2-methyl-8-p-toluene-
sulphonamido-6-quinoloxy)acetate (Zinquin-E) from Luminis Pty 
Ltd. (Adelaide, Australia). SNOC and DETA/NO (l-hydroxy-2-oxo-
3,3-bis(2-aminoethyl)-l-triazene) were synthesized as described [8,9]. 
SNOC-No and D E T A / N O - N O were obtained by incubating a 100 
mM stock solution of SNOC for 24 h and a 50 mM stock solution 
of DETA/NO for 72 h at 37°C. The Zn(II)-histidine complex for 
loading cells with Zn2+ was prepared by dissolving 25 mM ZnCl2 
and 50 mM L-histidine-HCl in 1 ml of H 2 0 and neutralizing with 
1 M NaOH as described [10]. 
For all cell cultures RPMI-1640, pH 7.2, was used, supplemented 
with 6 x l 0 4 U/l penicillin, 60 mg/1 streptomycin, 1 mM sodium-pyr-
uvate, 2 mM glutamine, 10 ml/1 non-essential amino acids (100-fold 
concentrated), 10 mM HEPES (all from Gibco), and 10% heat-inac-
tivated fetal calf serum (FCS) purchased from PAA Laboratories 
(Linz, Austria). 
2.2. Target cells 
The mouse fibroblast cell line L929 was kindly provided by Dr. B. 
Urbaschek, University Heidelberg-Mannheim, Germany. Splenocytes 
were isolated from spleen of anesthesized NMRI-mice. For isolation 
the spleen was gently pressed through a nylon cell strainer (70 um, 
Becton Dickinson, Mountain View, CA). The resulting cell suspension 
was collected in HBSS, centrifuged (250Xg/5 min) and the cell pellet 
resuspended in HBSS. To remove erythrocytes, the cell suspension 
was mixed with 2 vol. of lysis buffer (10 mM KHCO3, 155 mM 
NH4C1, 0.1 mM EDTA, pH 7.4) and incubated for 25 min at 4°C. 
After centrifugation, the resulting lymphocyte cell pellet was dissolved 
in RPMI and cells were cultured at 37°C. Rat vascular aorta endo-
thelial cells were isolated by outgrowth from rat aortic rings exactly as 
described [11]. 
2.3. Labeling of cells and treatment with NO donors 
Cells (5X 105/well) were placed in 12-well flat-bottomed plates (Bec-
ton Dickinson) and incubated with 25 uM Zinquin-E for 30 min at 
37°C. Subsequently, Zinquin-labeled freshly isolated splenocytes, cul-
tured AEC and L929 cells, respectively, were incubated with SNOC or 
SNOC-NO for 1 h in serum-free RPMI at the concentrations indi-
cated. Alternatively, cells were cultured in the presence of DETA/NO 
or D E T A / N O - N O for 24 h in RPMI containing 2.5% FCS and were 
then labeled with Zinquin. Cells were then investigated under the 
fluorescence microscope (Axioplan, Zeiss, Oberkochen, Germany) 
with the Zeiss filter set number 02 (excitation 365 nm, emission LP 
420 nm). As a positive control, cells were loaded with Zn2+ as fol-
lows: cells were incubated with 100 uM of the Zn(II)-histidine com-
plex [10] for 1 h, washed, labeled with Zinquin-E and investigated as 
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described above. As a specificity control, NO-treated cells were incu-
bated with 200 uM of the Zn2+ chelator TPEN for 24 h, washed, 
labeled with Zinquin-E and investigated as described above. To ex-
clude a reaction between NO' and Zinquin or the Zinquin-Zn2+ com-
plex, Zinquin-E was incubated with SNOC in the presence or absence 
of Zn2+. After incubation of Zinquin-E with SNOC for 1 h at 37°C in 
the absence of Zn2+ , Zinquin-E did not become fluorescent. In addi-
tion, SNOC treatment did not inhibit or destroy the fluorescence 
activity of the Zinquin-E-Zn2+ complex. 
2.4. Flow cytometry 
Freshly isolated splenocytes were incubated with Zinquin-E plus 
SNOC or SNOC-No for 1 h. For flow cytometric analysis, data of 
104 stained as well as control cells were collected using a FACStarphls 
(Becton Dickinson) equipped with a 5-W argon ion laser (Innova 305, 
Coherent, Palo Alto, CA) operating at 100 mW in a multiline UV 
(333.6-363.8 nm) mode and analysed using FACStarplus research soft-
ware (Becton Dickinson). Side scatter was detected with a 330 nm 
bandpass filter (330WB60, Omega Optical, Brattleboro, VT). Zinquin 
fluorescence was measured through a 530 nm bandpass filter 
(530DF30) (Becton Dickinson) and propidium iodide fluorescence 
was detected at 610 nm (610FS10, Oriel, Stratford, CT). 
3. Results 
Zinquin-E is a non-fluorescent membrane-permeable fluo-
rophore, which by esterases is intracellularly converted to 
membrane-non-permeable Zinquin [12]. Upon specific binding 
of Zn2+, Zinquin becomes strongly fluorescent [13] which was 
used to detect NO-mediated modulation of intracellular free 
Zn2+ concentrations. 
Zinquin-labeled L929 cells were treated with NO donors 
and subsequently examined by fluorescence microscopy. Zin-
quin-labeled but otherwise untreated L929 cells showed a 
weak fluorescence in their cytoplasm with nuclei always un-
labeled (Fig. 1A). This demonstrates low concentrations of 
detectable free Zn2+ in cytoplasm and absence of free Zn2+ 
in nuclei. Transillumination confirmed that all cells within the 
L929 cultures were labeled (Fig. IB). Treatment of Zinquin-
labeled cells with SNOC or with DETA/NO resulted in strong 
fluorescence detectable over the total cellular area including 
the nuclei (Fig. 2A) indicative of an increase in detectable free 
intracellular Zn2+ within both, cytoplasm and nuclei. Maxi-
mal fluorescence was obtained after treatment with 10 mM 
SNOC for 1 h or with 2 mM DETA/NO for 24 h. All NO-
treated L929 cultures showed some variation of fluorescence 
intensities between individual cells, but transillumination 
showed labeling of all cells (Fig. 2B). Increases in labeling 
are not due to cytotoxicity as treatment of L929 cells with 
10 mM SNOC for 1 h or with 2 mM DETA/NO for 24 h 
resulted in about 7% and 5% dead cells, respectively, as de-
termined by trypan blue exclusion. As negative controls we 
used the denitrosylated compounds S N O C - N O (10 mM) and 
DETA/NO-No (2 mM). Treatment with both control agents 
under otherwise unchanged conditions resulted in fluorescence 
intensities exactly as in untreated cells. As a control for Zn2+ 
specificity, L929 cells were treated with SNOC and then with 
the Zn2+ chelator TPEN. Subsequent treatment with Zinquin-
E resulted in fluorescence intensities identical to negative con-
trols as an indication of specificity (not shown). As a positive 
control, L929 cells were preloaded with zinc ions via a Zn(II)-
histidine complex prior to Zinquin labeling. Cells thus treated 
exhibited a strong fluorescence in the cytoplasm as well as in 
the nuclei comparable to fluorescence of Zinquin-labeled plus 
NO-treated cells (not shown). This also indicates that the lack 
of fluorescence in control nuclei is not due to the inability of 
Zinquin to enter the nuclei. 
NO-mediated effects were also found with non-transformed 
primary cells. Exactly the same experiments as described 
above were performed with primary cultured aorta endothelial 
cells (AEC) and with freshly isolated mouse splenocytes. AEC 
exhibited no fluorescence after Zinquin labeling with no fur-
ther treatment (Fig. 3A). When AEC were labeled and treated 
with SNOC (2 mM) for 1 h with DETA/NO (2 mM) for 24 h, 
each cell within the culture showed homogenous strong fluo-
rescence throughout the total cellular area (Fig. 4A). Identical 
results were obtained with splenocytes when incubated with 10 
mM SNOC for 1 h (not shown). 
For further quantification of the effects described above, we 
analyzed NO-mediated Zn2+ release by flow cytometry of 
freshly isolated splenocytes incubated exactly as described 
above. Untreated unlabeled (Fig. 5A) and SNOC-treated un-
labeled cells (Fig. 5B), respectively, exhibited background flu-
orescence intensities only. A minor increase in fluorescence 
intensity was found in labeled but untreated cells (Fig. 5C) 
as well as labeled plus S N O C - N O treated cells (Fig. 5E). In 
contrast, a highly significant increase in fluorescence intensity 
of the total cell population was obtained with labeled and 
SNOC-treated cells (Fig. 5D). These data exactly match the 
results obtained with fluorescence microscopy. 
4. Discussion 
One effect of NO' towards cells is the destruction of Fe-S 
clusters in proteins and the intracellular release of iron (for 
review see [14]). We have found in addition that in vitro under 
aerobic conditions NO' also mediates Zn2+ release from the 
Zn2+ storage protein metallothionein via S-nitrosylation and 
destroys the DNA-binding activity of the yeast zinc finger 
transcription factor LAC9 [6]. We now show, that exogenous 
NO' indeed leads to increases of detectable free Zn2+ concen-
trations within living cells as detected with the fluorophore 
Zinquin. As sources for NO' we used two unrelated chemical 
NO donors, SNOC and DETA/NO, respectively. The concen-
trations used, i.e. 2-10 mM SNOC for 1 h or 2 mM DETA/ 
NO for 24 h appear relatively high. However, in cell culture 
media SNOC has a half-life in the range of several minutes 
only. Cultures thus are exposed to a burst of NO' most of 
which probably will be autoxidized or will react with media 
components before reaching the target cells at the bottom of 
the culture dish. In contrast, DETA/NO spontaneously re-
leases NO' with predictable first-order kinetics [15] thereby 
providing a constant NO' discharge over hours. We deter-
mined a half-life of 7.7 ±0.8 h (n = 3) for DETA/NO at 
Figs. \-A. Fluorescence and transillumination micrographs of Zinquin-labeled cells with or without NO-treatment. L929 cells (Figs. 1+2) or rat 
vascular aorta endothelial cells (Figs. 3+4) were labeled with Zinquin-E and observed for fluorescence (Figs. 1-4A) or with transillummation 
(Figs. 1-4B). Low or absent fluorescence (Figs. 1A+3A) was found after Zinquin-labeling and no further treatment. Treatment of Zinquin-la-
beled L929 cells with 10 mM SNOC for 1 h (Fig. 2A) or of endothelial cells with 2 mM DETA/NO for 24 h (Fig. 4A) resulted in strongly en-
hanced blue fluorescence all over the cytoplasm and the nuclei of every cell. Magnifications: X300. 
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Fig. 5. Histograms of unstained and of SNOC, Zinquin, Zinquin+ 
SNOC and Zinquin+SNOC_NO incubated mouse spleen cells, re-
spectively. Gating of living splenocytes was performed according to 
light scatter and propidium iodide (0.4 ug/ml) fluorescence. The his-
tograms show: (A) unstained cells, (B) unstained cells treated with 
10 mM SNOC (as SNOC treatment control), (C) Zinquin-stained 
but not otherwise treated cells (as Zinquin-staining control), (D) 
Zinquin-stained+SNOC (10 mM) incubated cells, and (E) Zinquin-
stained+SNOC_N0 (10 mM) incubated cells. The Zinquin-+SNOC-
treated mouse spleen cells are shifted to 100% into the positive log-
scale. Shown are the results of one out of three identical experi-
ments. 
37°C, pH 7.4. According to the first-order kinetic laws 
(ii/2 = ln2/k and c = c0-e
_kt), 2 mM of DETA/NO generate 
6.6 nM NO' per minute. Recently a steady-state concentration 
of about 4-5 |xM of NO' has been calculated to be present in 
the immediate vicinity of a cell monolayer which enzymati-
cally generates NO' [16]. In consideration of these calcula-
tions, the DETA/NO concentrations used appear well within 
the range of physiological events. 
Zinquin fluorescence is highly specific for Zn2+. Otherwise, 
only Cd2+, which is a rare constituent of biological tissues, 
weakly enhances Zinquin fluorescence, but no other metal ion, 
including Fe2+ and Fe3+, increase Zinquin fluorescence [13]. 
The results presented here thus demonstrate that treatment of 
cells with NO donors results in an increase of the intracellular 
free Zn2+ concentrations throughout the whole cellular area 
including the nuclei. Identical experiments in the additional 
presence of a Zn2+ chelator resulted in significantly reduced 
fluorescence intensities showing that we indeed measured a 
specific Zn2+ release within the cells. Preloading of cells 
with Zn2+ prior to Zinquin treatment and no NO-donor ad-
dition revealed increased labeling also in the nuclear compart-
ment demonstrating that nuclear fluorescence after NO treat-
ment is not due to NO-mediated translocation or access of 
Zinquin to the nucleus but indeed reflects a local release of 
Zn2+. Our experiments suggest that NO' may be able to tra-
verse the cellular cytoplasm and to react with targets in nuclei. 
Although the effects may well be secondary in nature, we 
clearly show that exogenously generated NO' can lead to 
changes even within the nuclear compartment. Local Zn2+ 
release in nuclei appears to be associated with the destruction 
of zinc finger or zinc finger-related protein structures and 
would thereby lead to altered gene expression patterns. In 
view of the recently described activation of a transcription 
factor via reversible S-nitrosylation [17] an important and 
new function now emerges for NO' as regulator signal within 
live cells. 
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